Kedudukan dalam Saham
#16218
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Harga Saham
$3.70
Disegerakkan terakhir: 2026-07-31
Perubahan (1 hari)
-3.53%
Perubahan (1 tahun)
203.66%
Perdagangan Opus Genetics, Inc. (IRD)
Harga IRD dengan permodalan pasaran b
Modal pasaran bagi Opus Genetics, Inc.(IRD)
Modal Pasaran: $305.87M
Sehingga September 2026, Opus Genetics, Inc. mempunyai modal pasaran sebanyak $305.87M. Ini menjadikan Opus Genetics, Inc. syarikat ke-16218th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Opus Genetics, Inc. dari 2024 hingga 2026
IRD berbanding dengan 5 teratas yang paling popular stocks
| Harga IRD |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.260T
|
+1,719,438.14%
|
|
|
|
|
$4.779T
|
+1,562,157.96%
|
|
|
|
|
$4.017T
|
+1,313,103.81%
|
|
|
|
|
$3.719T
|
+1,215,863.74%
|
|
|
|
|
$2.734T
|
+893,812.25%
|
